## HUBB: Hubbell Inc - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -3.5% below STRENGTH zone (4.0-10.0%); PEG 2.25 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (52% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($403.45)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Hubbell Inc $HUBB Shares Sold by Neuberger Berman Group LLC**
- Source: MarketBeat | 20251201T010952 | Somewhat-Bullish | Relevance: 100%
-  Neuberger Berman Group LLC significantly reduced its stake in Hubbell Inc. (NYSE: HUBB) in Q2, selling 61,260 shares. Despite this, other institutional investors increased their holdings, and Hubbell insiders also sold shares in November. Wall Street analysts maintain a "Moderate Buy" rating for HUBB with an average target price of $474.00, and the company recently increased its quarterly dividend to $1.42.

**2. Electrical Systems Stocks Q3 In Review: Hubbell (NYSE:HUBB) Vs Peers**
- Source: Markets Financial Content | 20251201T033400 | Neutral | Relevance: 98%
- This article reviews the Q3 2025 performance of Hubbell (NYSE: HUBB) and other electrical systems stocks, highlighting their financial results against analyst expectations. It discusses overall sector trends, individual company performance including revenue beats and misses, and provides a broader market update regarding inflation, interest rates, and stock market highs.

**3. Electrical Systems Stocks Q3 In Review: Hubbell (NYSE:HUBB) Vs Peers**
- Source: TradingView | 20251201T110628 | Neutral | Relevance: 97%
- This article reviews the Q3 performance of Hubbell (NYSE:HUBB) and several of its peers in the electrical systems sector. While the sector as a whole reported strong revenues, Hubbell delivered the weakest performance against analyst estimates. Companies like Thermon (THR) and LSI (LYTS) showed strong revenue beats, highlighting varied performance within the industry.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-20 | UBS | $450 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-20 | UBS | init | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($0.27M) |
| Sells | 3 ($1.53M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (-0.6%)
- Blackrock Inc.: 8.8% (-6.9%)
- State Street Corpora: 4.3% (+3.6%)
- Bank Of New York Mel: 4.2% (-10.9%)
- JPMORGAN CHASE & CO: 3.3% (+69.7%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.25 elevated, pricing in significant growth expectations. Forward P/E 21.7x stretched relative to 8% growth. Quality metrics strong (ROE 25%, margin 15%). Insider selling cluster ($1.5M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $23.8B |
| Beta | 1.00 |
| 52W Range | $299.43 - $484.26 |
| Short Interest | 5.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.25 |
| Forward P/E | 21.7 |
| Current P/E | 23.5 |
| YoY Growth | 8.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 improving modestly (+0.7% over 5 days). Below STRENGTH zone by 7.5pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.07x) but short-term weakness (below SMA20). MACD histogram bearish (-1.12), momentum weakening. RSI neutral at 46. Volume at 52% of 20MA suggests lack of conviction.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.50% (CS: 15) | Weak |
| RSI_14 | 45.7 | Neutral |
| MACD Histogram | -1.12 | Bearish |
| vs SMA20 | 0.974x | Below |
| vs SMA50 | 0.985x | Below |
| vs SMA200 | 1.066x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $427.85
- **Stop Loss:** $403.45 (5.7% risk)
- **Target:** $452.25 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 20
- **Position Value:** $8,557.00
- **Portfolio %:** 8.56%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-02-03 (Est: $4.69)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.98 | $5.17 | +3.9% |
| 2025Q2 | $4.40 | $4.93 | +12.1% |
| 2025Q1 | $3.72 | $3.50 | -6.0% |
| 2024Q4 | $4.02 | $4.10 | +2.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*